You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is A patient having glaucoma develops blepharoconjunctivitis after instilling some antiglaucoma drug. Which of the following drug can be responsible for it – and explain in detail?
Ocular side effects of topical agents for POAG
β-blockers :

Allergic blepheroconjunctivitis, corneal hyposthesia, Blurred vision, Dryness of eye, superficial punctate keratitis.

Cholinomimetics (Pilocarpine) :

Blurred vision, miosis, accommodative spasm, browache.

Symathomimetics :

Non-selective (Dipivefrine) :- Follicular conjunctivitis, rebound congestion, macular edema in aphakic.
Brimonidine: - Conjunctival blanching, ocular allergy.
Apraclonidine: - Allergies, fluctuation in visual acuity.

Carbonic anhydrase inhibitors (Dorzolamide, Brinzolamide) Punctate keratitis, ocular allergies.
Prostaglandin analogues (Latanoprost) Punctate keratitis, iris pigmentation.